Status:
RECRUITING
The Effect of AFOs on the EMG of Children With CP
Lead Sponsor:
Universitaire Ziekenhuizen KU Leuven
Conditions:
Spastic Cerebral Palsy
Eligibility:
All Genders
6-17 years
Brief Summary
Children with cerebral palsy (CP) have altered gait patterns as a result of primary and secondary symptoms. Ankle-foot orthoses (AFOs) are frequently used to improve their gait. Despite evidence of AF...
Detailed Description
With a prevalence of two to three per 1000 live births, Cerebral Palsy (CP) is the most common motor disability of childhood. Improving disturbed gait in ambulatory children with CP is an important tr...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Gross Motor Function Classification System (GMFCS) level I - III
- CP (bilateral \& unilateral)
- Age: 6 - 17 years
- Prescribed AFO by the medical team (as part of the standard care)
- Exclusion criteria:
- Severe contractures or spasticity, which makes it impossible to wear a conventional AFO
- Cognitive or visual impairment that hinder them to understand instructions
- Previous surgery on bones and/or muscles of the legs in the last 12 months prior to assessment
- Presence of ataxia or dystonia
Exclusion
Key Trial Info
Start Date :
January 6 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 31 2025
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT06532981
Start Date
January 6 2023
End Date
July 31 2025
Last Update
April 30 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UZ Leuven
Leuven, Vlaams-Brabant, Belgium, 3000